All submissions require a data availability statement describing where data are stored, how they can be accessed, or why access is restricted.

• Public repositories with persistent identifiers
• Controlled access repositories for sensitive clinical data
• Data available from the corresponding author on reasonable request
• Data included within the article or supplementary files

Statements should specify access conditions, embargo periods, and any data use agreements or ethical limits.

Select repositories that provide stable access, metadata quality, and clear reuse terms.

Remove personal identifiers and confirm consent for data sharing. Sensitive datasets should use controlled access with clear governance.

If embargo periods apply, state the timeline and access conditions in the data availability statement.

Integrative health studies often include mixed data types such as clinical assessments, patient reported outcomes, biosignals, and qualitative interviews. Organize files with clear naming conventions and consistent units.

• Clinical measurements and laboratory data in CSV format
• Questionnaire instruments with scoring documentation
• Audio or transcript files for qualitative studies
• Intervention protocols and practitioner training materials

When data are sensitive or involve ongoing clinical programs, authors may request embargo periods. Provide a clear end date and the rationale for restricted access.

For controlled access datasets, describe the application process, review timeline, and any data use agreements required.

Cite datasets in the reference list using persistent identifiers. Include repository name, accession number, and version details when available.

Clear data citation supports attribution and encourages responsible reuse by other researchers.

Maintain archived datasets for long term access and document any version updates. When updated files are posted, include version numbers and a brief change summary.

Preservation practices support replication studies and long term evaluation of integrative therapies.

If data are available upon request, provide a clear contact method and expected response timeline. Requests should be evaluated consistently and without unreasonable barriers.

For sensitive clinical or community data, document the anonymization steps and ethical approvals for sharing. Controlled access repositories should include governance procedures to protect participants.

Authors should confirm that archived datasets match reported results and that derived files are clearly documented.

Consistency across files improves reuse.

Provide a data dictionary that defines variables, coding, and missing value conventions. Include readme files that describe file structure and software requirements.

Use open and non proprietary formats when possible, such as CSV for tables and TXT or PDF for documentation.

Define access levels clearly, including open, controlled, and restricted access. When reuse requires approval, provide a clear application process and contact details.

For clinical datasets, include data use agreements and oversight processes that protect participant privacy while enabling reproducible research.

• Data availability statement with repository links
• De identification and consent confirmation
• Data dictionary and readme documentation
• Code and workflow files with version details
• Access conditions and contact details if restricted

Clear reuse guidance supports responsible secondary analysis and encourages proper attribution.